The Role of Sentinel Lymph Node Biopsy with Blue Dye Alone in Breast Cancer Patients with Excisional Biopsy

References

• Hsueh E. e., Turner R. R., Glass E. C., Brenner R. J., Brennan M. B., Giuliano A. E. Sentinel node biopsy in breast cancer. J Am Coll Surg, 1999, 189: 183–94.
   Google Scholar
• Nieweg O. E., Rutgers E. J., Jansen L. et al. Is lymphatic mapping in breast cancer adequate and safe ? World J Surg, 2001, 25: 7808.
   Google Scholar
• Hill A. D., Tran K. N., Akhurst T. et al. Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg, 1999, 229: 528–35.
   Google Scholar
• Giuliano A. E., Kirgan D. M., Guenther J. M., Morton D. L. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg, 1994, 220: 391–401.
   Google Scholar
• Giuliano A. E., Jones R. C., Brennan M., Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol, 1997, 15: 234550.
   Google Scholar
• Jatoi A. Management of the axilla in primary breast cancer. Surg Clin North Am, 1999, 79: 1061–72.
   Google Scholar
• Bass S. S., Charles E. C., Ku N. N., Berman C., Reintgen D. S. The role of sentinel lymph node biopsy in breast cancer. J Am Coll Surg, 1999, 189: 183–94.
   Google Scholar
• Rahusen F. D., Pijpers R., van Diest P. J., Bleichrodt R. P., Torrenga H., Meijer S. The implementation of the sentinel node biopsy as a routine procedure for patients with breast cancer. Surgery, 2000, 128: 6–12.
   Google Scholar
• Feldman S. M., Krag D. N., McNally R. K., Moor B. B., Weaver D. L., Klein P. Limitation of gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy. J Am Coll Surg, 1999, 188: 248–54.
   Google Scholar
• Ververs J. M., Roumen R. M., Vingerhoets A. J. et al. Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer, 2001, 37: 991–9.
   Google Scholar
• Veronesi U., Galimberti v., Zurrida S. et al. Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer. Eur J Cancer, 2001, 37: 454–8.
   Google Scholar
• Krag D., Weaver D., Ashikaga T. et al. The sentinel node in breast cancer: a multicentre validation study. N Engl J Med, 1998, 339: 941–6.
   Google Scholar
• Ozmen v., Muslumanoglu M., Cabioglu N. et al. Increased false negative rates in sentinel lymph node biopsies in patients with multi-focal breast cancer. Breast Cancer Res Treat, 2002, 76: 237–44.
   Google Scholar
• Whitworth P., McMasters K. M., Tafra L., Edwards M. J. State-of-the-art lymph node staging for breast cancer in the year, 2000. Am J Surg, 2000, 180: 262–7.
   Google Scholar
• Tsunoda N., Iwata H., Sarumaru S., Mizutani M., Iwase T., Miura S. Combination of subareolar blue dye and peritumoral Ri for sentinel lymph node biopsy. Breast Cancer, 2002, 9: 3238.
   Google Scholar
• Albo D., Ames F. C., Hunt K. K., Ross M. I., Singletary S. E., Kuerer H. M. Evaluation of lymph node status in male breast cancer patients: a role for sentinel lymph node biopsy. Breast Cancer Res Treat, 2003, 77: 9–14.
   Google Scholar
• Morrow M., Rademaker A. W., Bethke K. P. et al. Learning sentinel node biopsy: results of a prospective randomized trial of two techniques. Surgery, 1999, 126: 714–22.
   Google Scholar
• Albertini J. J., Lyman G. H., Cox C. et al. Lymphatic mapping and sentinel lymph node biopsy in the breast cancer patient. JAMA, 1996, 276: 1818–22.
   Google Scholar
• Cody III H. S., Borgen P. I. State-of-the-art approaches to sentinel node biopsy for breast cancer: study design, patient selection, technique and quality control at Memorial sloan-Kettering Cancer Center. Surg Oncol, 1999, 8: 85–91.
   Google Scholar
• Chetty U. Axillary node sample to evaluate the axilla. World J Surg, 2001, 25: 773–9.
   Google Scholar
• Ollila D. W., Guiliano A. E. Intra-operative lymphatic mapping and sentinel lymphadenectomy using isosulfan blue dye. Breast Dis, 1998, 8: 297–300.
   Google Scholar
• Veronesi U., Paganelli G., Galimberi v. et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet, 1997, 349: 1864–7.
   Google Scholar
• Borgstein P. J., Pijpers R., Comans E. F., van Diest P. J., Boom R. P., Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg, 1998, 186: 275–83.
   Google Scholar
• Wong S. L., Edwards M. J., Chao C. et al. The effect of prior breast biopsy method and the concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy. Ann Surg Oncol, 2002, 9: 272–7.
   Google Scholar
• Haigh P. I., Hansen N. M., Qi K., Giuliano A. E. Biopsy method and excision volume do not affect the success rate of subsequent sentinel lymph node dissection in breast cancer. Ann Surg Oncol, 2000, 7: 21–7.
   Google Scholar
• Olson J. A. Jr., Fey J., Winawer J. et al. Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer. J Am Coll Surg, 2000, 191: 593–9.
   Google Scholar
• Noguchi M., Motomura S., Imoto S. et al. A multicentre validation study of sentinel lymph node biopsy by the Japanese Breast Cancer Society. Breast Cancer Res Treat, 2000, 63: 31–40.
   Google Scholar
• Borgstein P. J., Meijer S., Pijpers R., van Diest P. J. Functional lymphatic anatomy for sentinel node biopsy in breast cancer. Ann Surg, 2000, 232: 81–9.
   Google Scholar
• Uren R. F., Howman-Giles R., Renwick S. B., Gillett D. Lymphatic mapping of the breast: locating the sentinel lymph nodes. World J Surg, 2001, 25: 789–93.
   Google Scholar